Breeze3:Study of Gabapentin Extended Release in the Treatment of Vasomotor Symptoms(Hot Flashes)in Postmenopausal Women

Inclusion Criteria

• •Generally healthy, postmenopausal women who seek treatment for hot flashes
• •Patients using hormone replacement therapy(HRT) must be willing to discontinue treatment
• •Patients must be experiencing moderate to severe hot flashes
• •Patients must be able to sign the informed consent
• •Patients must be able to enter simple commands and complete questionnaires on the frequency and severity of their hot flashes using an electronic diary
• •Other inclusions apply.